New Xarelto Lawsuit Alleges Manufacturers of Blood Thinner Made Misleading Claims to Promote Medication, Bernstein Liebhard LLP Reports

The Firm is evaluating Xarelto lawsuits on behalf of individuals who allegedly suffered intracranial hemorrhage, spinal and epidural hematoma, gastrointestinal hemorrhage, adrenal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death due to their use of the blood thinner.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
Our Firm has heard from a number of Xarelto patients who claim to have experienced life-threatening episodes of internal bleeding similar to the injuries alleged in this lawsuit.

New York, NY (PRWEB) August 13, 2014

Xarelto lawsuits (http://www.injurybeacon.com/xarelto/lawsuit/) filed on behalf of individuals who were allegedly harmed by the blood thinner continue to mount in U.S. courts, Bernstein Liebhard LLP reports. Court documents pending in the U.S. District Court, Eastern District of New York indicate that a woman from Texas has filed a case against Johnson & Johnson and Bayer HealthCare that accuses the companies of making misleading claims in order to market Xarelto. According to the July 29th filing, the Plaintiff took Xarelto for just four months starting in March 2012, and suffered a life-threatening bleed that left her with severe and permanent injuries. (Case 1:14-cv-04524-DLI-MDG)

Among other things, the complaint alleges that Johnson & Johnson and Bayer failed to warn doctors and patients about the irreversible nature of Xarelto bleeding. It further alleges that the companies wrongly touted the drug as a superior alternative to warfarin, a blood thinner that has been in use for decades. Among other things, the Xarelto lawsuit also points out that the Defendants received a letter from the U.S. Food & Drug Administration’s (FDA) Office of Prescription Drug Promotion in July 2013 that characterized a Xarelto print ad as “false or misleading” because it minimized risks associated with the drug, and made a misleading claim regarding dosage adjustment.

“Our Firm has heard from a number of Xarelto patients who claim to have experienced life-threatening episodes of internal bleeding similar to the injuries alleged in this lawsuit,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering Xarelto case reviews to people who allegedly suffered serious injuries from the blood thinner, including intracranial hemorrhage, spinal and epidural hematoma, gastrointestinal hemorrhage, adrenal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death.

Xarelto Litigation
According to a recent Reuters report, this claim is just one of several Xarelto lawusits pending in U.S. courts.* The Plaintiff in the New York case alleges that the manufacturers of the drug failed to warn that there is currently no approved antidote to reverse Xarelto bleeding. The complaint points out that while both warfarin and Xarelto can cause internal bleeding, this occurrence can be halted in warfarin patients via the administration of vitamin K.

In June, the Institute for Safe Medicine Practices reported that adverse events associated with the use of Xarelto are on the rise. According to data from the FDA, the agency received a total of 680 Xarelto adverse event reports in the first quarter of 2013. For the first time, reports of Xarelto complications outpaced those associated with Pradaxa, another blood thinner in the same class, according to the ISMP.**

Individuals who were allegedly harmed by Xarelto may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a Xarelto lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to schedule a free, no obligation case review.

*reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614, Reuters.com, June 14, 2014.
**ismp.org/quarterwatch/pdfs/2013Q1.pdf, Institute for Safe Medication Practices, May 7, 2014.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.injurybeacon.com
https://plus.google.com/115936073311125306742?rel=author